Hepatic Steatosis in the Pediatric Population: An Overview of Pathophysiology, Genetics, and Diagnostic Workup.
作者信息
Phen Claudia, Ramirez Charina M
机构信息
Division of Pediatric Gastroenterology, Hepatology and Nutrition University of Texas Southwestern Medical Center Children's Health Dallas TX.
出版信息
Clin Liver Dis (Hoboken). 2021 Apr 13;17(3):191-195. doi: 10.1002/cld.1008. eCollection 2021 Mar.
Abstract
摘要
相似文献
1
Hepatic Steatosis in the Pediatric Population: An Overview of Pathophysiology, Genetics, and Diagnostic Workup.儿童人群中的肝脂肪变性：病理生理学、遗传学及诊断检查概述
Clin Liver Dis (Hoboken). 2021 Apr 13;17(3):191-195. doi: 10.1002/cld.1008. eCollection 2021 Mar.
2
Detection of pediatric hepatic steatosis through ultrasound backscattering analysis.通过超声背散射分析检测小儿肝脂肪变性。
Eur Radiol. 2021 May;31(5):3216-3225. doi: 10.1007/s00330-020-07391-7. Epub 2020 Oct 30.
3
[Diagnostic value of non-invasive model for hepatic steatosis in patients infected with human immunodeficiency virus].[人类免疫缺陷病毒感染患者肝脂肪变性无创模型的诊断价值]
Zhonghua Gan Zang Bing Za Zhi. 2020 Sep 20;28(9):790-793. doi: 10.3760/cma.j.cn501113-20200820-00469.
4
A Practical Approach to Quantitative Grayscale Ultrasound Analysis of Hepatic Steatosis in Pediatric Patients Using a Picture Archiving and Communication System-Based Tool.一种使用基于图像存档与通信系统的工具对儿科患者肝脂肪变性进行定量灰阶超声分析的实用方法。
J Ultrasound Med. 2018 Oct;37(10):2395-2403. doi: 10.1002/jum.14598. Epub 2018 Mar 25.
5
Pediatric nonalcoholic fatty liver disease.小儿非酒精性脂肪性肝病
Gastroenterol Nurs. 2008 Mar-Apr;31(2):115-9. doi: 10.1097/01.SGA.0000316530.31366.6e.
6
Reproductive history and chronic hepatic steatosis in the Michigan Study of Women's Health Across the Nation.全国妇女健康密歇根研究中的生殖史与慢性肝脂肪变性
J Womens Health (Larchmt). 2015 Jan;24(1):42-8. doi: 10.1089/jwh.2014.4839. Epub 2014 Dec 30.
7
Hepatic steatosis in obese Chinese children.肥胖中国儿童的肝脂肪变性
Int J Obes Relat Metab Disord. 2004 Oct;28(10):1257-63. doi: 10.1038/sj.ijo.0802734.
8
Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients.鲁马卡托/依伐卡托疗法与囊性纤维化患者肝脂肪变性减轻相关。
World J Hepatol. 2019 Dec 27;11(12):761-772. doi: 10.4254/wjh.v11.i12.761.
9
Comparative Assessment and External Validation of Hepatic Steatosis Formulae in a Community-Based Setting.社区环境中肝脂肪变性公式的比较评估与外部验证
J Clin Med. 2020 Sep 3;9(9):2851. doi: 10.3390/jcm9092851.
10
Incidence and Diagnostic Evaluation of Postoperative Fever in Pediatric Patients With Neuromuscular Disorders.神经肌肉疾病患儿术后发热的发病率及诊断评估
J Pediatr Orthop. 2018 Feb;38(2):e104-e110. doi: 10.1097/BPO.0000000000001103.
引用本文的文献
1
Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025.肥胖儿童的代谢功能障碍相关脂肪性肝病（MASLD）：肥胖医学协会（OMA）与专家联合观点（2025年）
Obes Pillars. 2025 Feb 1;14:100164. doi: 10.1016/j.obpill.2025.100164. eCollection 2025 Jun.
2
Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: a single-blind, randomized clinical trial.评估富含生育三烯酚的维生素 E 对非酒精性脂肪性肝病肥胖儿童的疗效：一项单盲、随机临床试验。
BMC Pediatr. 2024 Aug 20;24(1):529. doi: 10.1186/s12887-024-04993-8.
3
Food insecurity is a risk factor for metabolic dysfunction-associated steatotic liver disease in Latinx children.食物不安全是拉丁裔儿童代谢功能障碍相关脂肪性肝病的一个风险因素。
Pediatr Obes. 2024 Jun;19(6):e13109. doi: 10.1111/ijpo.13109. Epub 2024 Mar 7.
4
Noninvasive assessment of paediatric hepatic steatosis by using attenuation imaging.利用衰减成像技术无创评估小儿肝脂肪变性。
Eur Radiol. 2023 Nov;33(11):8353-8365. doi: 10.1007/s00330-023-09731-9. Epub 2023 May 17.
本文引用的文献
1
The rs72613567: TA Variant in the Hydroxysteroid 17-beta Dehydrogenase 13 Gene Reduces Liver Damage in Obese Children.羟甾体 17-β 脱氢酶 13 基因中的 rs72613567:TA 变体可减少肥胖儿童的肝损伤。
J Pediatr Gastroenterol Nutr. 2020 Mar;70(3):371-374. doi: 10.1097/MPG.0000000000002573.
2
NAFLD in children: new genes, new diagnostic modalities and new drugs.儿童非酒精性脂肪性肝病：新基因、新诊断方法和新药物。
Nat Rev Gastroenterol Hepatol. 2019 Sep;16(9):517-530. doi: 10.1038/s41575-019-0169-z. Epub 2019 Jul 5.
3
Update on pathogenesis, diagnostics and therapy of nonalcoholic fatty liver disease in children.儿童非酒精性脂肪性肝病的发病机制、诊断与治疗进展
Clin Exp Hepatol. 2019 Mar;5(1):11-21. doi: 10.5114/ceh.2019.83152. Epub 2019 Feb 20.
4
Lipid mediators of liver injury in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中肝损伤的脂质介质。
Am J Physiol Gastrointest Liver Physiol. 2019 Jan 1;316(1):G75-G81. doi: 10.1152/ajpgi.00170.2018. Epub 2018 Nov 1.
5
A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease.一种截短蛋白的HSD17B13变体与慢性肝病的防护
N Engl J Med. 2018 Mar 22;378(12):1096-1106. doi: 10.1056/NEJMoa1712191.
6
Paediatric fatty liver disease (PeFLD): All is not NAFLD - Pathophysiological insights and approach to management.儿科脂肪性肝病（PeFLD）：并非所有都为非酒精性脂肪性肝病——病理生理学见解与管理方法。
J Hepatol. 2018 Jun;68(6):1286-1299. doi: 10.1016/j.jhep.2018.02.006. Epub 2018 Feb 20.
7
Genetics and epigenetics of NAFLD and NASH: Clinical impact.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的遗传学和表观遗传学：临床影响。
J Hepatol. 2018 Feb;68(2):268-279. doi: 10.1016/j.jhep.2017.09.003. Epub 2017 Nov 6.
8
NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).NASPGHAN儿童非酒精性脂肪性肝病诊断与治疗临床实践指南：非酒精性脂肪性肝病专家委员会（ECON）及北美儿科胃肠病学、肝病学和营养学会（NASPGHAN）的建议
J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):319-334. doi: 10.1097/MPG.0000000000001482.
9
Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.影响非酒精性脂肪性肝病的遗传因素：一项系统的临床综述。
World J Gastroenterol. 2016 Aug 7;22(29):6742-56. doi: 10.3748/wjg.v22.i29.6742.
10
The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans.MBOAT7基因变异体rs641738改变肝脏磷脂酰肌醇并增加人类非酒精性脂肪性肝病的严重程度。
J Hepatol. 2016 Dec;65(6):1263-1265. doi: 10.1016/j.jhep.2016.07.045. Epub 2016 Aug 9.
Zotero 插件